Nextech AR Solutions Corp. (CSE:NTAR, OTCQB:NEXCF) showed a rapid uptake of its augmented reality 3D model subscription business during third quarter 2022, placing it squarely in the way of a boom in revenue, according to Zacks Investment Research.
A Zacks analyst said that, as one of the first movers in a multi-billion dollar market, Nextech should be able to grow rapidly as this nascent AR sector explodes.
Black Swan Graphene (TSX-V:SWAN) Inc announced it has launched a scoping study in partnership with engineering firm Halyard Inc.
The large-scale production engineering study will provide an initial evaluation of the project, including processing plant specifications as well as mechanical, civil, structural, and electrical designs, Black Swan said in a statement.
Phunware Inc said Russ Buyse has been hired as the company’s chief executive officer, effective December 28, 2022.
Prior to joining Phunware, Buyse spent the past two decades in both product and services companies, from start-ups to enterprises, leading teams to create innovative solutions.
Ncondezi Energy Ltd (AIM:NCCL, OTC:NCDZF) has provided updated guidance on the financial potential of its planned solar and battery energy storage project in the Tete Province of Mozambique.
The operation is expected to scale from an initial 100MW to 300MW, resulting in cash flows over the 25-year life of the assets of US$186mln rising to US$400mln at 200MW and US$584mln at 300MW.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) has kicked off drilling operations at the State 36-2 LNW-CC well at the Paradox project in Utah, where it is targeting the Cane Creek reservoir.
The company, in a statement, detailed that the well programme will comprise 20,456 feet of vertical and some 10,346 feet of horizontal drilling.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) has hailed as one of the “most significant discoveries made in West Africa over the last decade” a major gold find in Côte d’Ivoire.
It said the Tanda-Iguela property has the potential to become another flagship asset after the company’s geologists compiled a resource estimate for the Assafou target in a super-quick 15 months.
Emmerson PLC (AIM:EML, OTC:EMSNF) has signed non-binding memoranda of understanding (MOUs) relating to the offtake of potash and salt to be produced at its Khemisset mine in Morocco.
Two memoranda have been signed.
Bradda Head Lithium Limited (AIM:BHL, OTCQB:BHLIF, TSX-V:BHLI) has released results from soil sampling at its San Domingo lithium pegmatite project in in Arizona.
The sampling has identified a lithium-bearing trend that may be greater than three kilometres in length.
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) said it has filed an investigational new drug (IND) application with the US authorities for OK-101, its putative treatment for dry eye disease.
It plans to carry out a phase II trial after being allowed to skip the initial safety phase by the US Food and Drug Administration (FDA).
Chariot Ltd (AIM:CHAR, OTC:OIGLF) has formed a new joint venture through a 25% interest in a new South African electricity trading company, Etana Energy.
South Africa is the largest electricity market on the continent but has regular power outages due to insufficient supply.
Lake Resources NL (ASX:LKE, OTCQB:LLKKF) welcomes the resolution of a dispute between the company and its technology partner Lilac Solutions, enabling a reset of the relationship in order to focus on delivering the world-class Kachi Project in Catamarca Province, Argentina.
The companies have now agreed to an amended timeline which both are confident can be achieved.
Venture Minerals Limited (ASX:VMS, OTC:VTMLF) has kicked off drilling at a new, high-priority rare earth element (REE)-tin target at Mount Lindsay in Tasmania, 1.3 kilometres west of the recent shallow-clay-hosted Reward REE discovery.
The recent REE discovery at Reward sits in the hanging wall of the Tin Zones of Reward Deposit, which has an existing resource of 500,000 tonnes at 0.9% tin.
Naturally Splendid Enterprises Ltd. (TSX-V:NSP, OTC:NSPDF) said George Ragogna will be stepping down as CFO and a member of the Board of Directors effective immediately. Ragogna will remain with the company as an Independent Consultant, focusing his efforts on logistics and inventory management control system. Bryan Carson, current Executive VP and company co-founder, will step in as interim CFO. Naturally Splendid CEO Craig Goodwin said: “I would like to acknowledge and thank George for his efforts as CFO and director. George was able to streamline several accounting processes and develop an order desk system that would allow us to track and record all purchases and invoices efficiently. We look forward to the opportunity to work with George through this transition and on new projects.”
Champion Gaming Group Inc (TSX-V:WAGR) said it has granted an aggregate of 3,140,000 restricted share units (RSUs) to certain officers, employees and consultants of the company under the terms of its omnibus equity incentive compensation plan, vesting 12 months from the date of grant. Each RSU entitles the holder to acquire one common share of the company. The RSU grant is subject to approval by the TSX Venture Exchange.
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) said James Henning and Steven Inglefield have stepped down as directors of the company. “James has served on the Wellbeing board of directors since the company’s inception,” said Wellbeing CEO Najla Guthrie. “Overtime he has made many contributions to the success and growth of the company, drawing on a wealth of experience gained over a long and successful business career. Steven has served as a director of the company as well as its Chief Operating Officer since the purchase of IRP Health Ltd and made considerable contributions during his tenure. With the company’s decision to divest IRP, Steven leaves to focus on IRP’s expanding growth. On behalf of the board of directors, the management team and our shareholders, I thank James and Steven for their contributions and wish them the best in their future endeavours,” Guthrie added.
Bhang Inc (CSE:BHNG, OTCQB:BHNGF) announced that it has entered into a debt settlement agreement with a consultant that provided certain capital markets advisory services. As per the terms of the settlement agreement, Bhang has issued 3,766,666 units of Bhang at a price of $0.03 per unit, in full and final satisfaction of the indebtedness in the amount of $113,000 owed by the company to the consultant. Each unit is comprised of one subordinate voting share of Bhang and one half warrant. Each full warrant is exercisable for one subordinate voting share of Bhang at a price of $0.05 per subordinate voting share for a period of 12 months. Bhang said it has also issued 1,940,257 subordinate voting shares at a price of $0.035 per share pursuant to an agreement for the license of certain software and data relating to industry reporting. The subordinate voting shares and underlying subordinate voting shares to the warrants are subject to a statutory four month and one day hold period expiring on March 19, 2023.
MedX Health Corp. (TSX-V:MDX) is proposing to complete a private placement financing to raise up to $1.5 million by issuing a five-year secured convertible debenture. Under the terms of the proposed placement, which is subject to acceptance by the TSX Venture Exchange and any other relevant regulatory or other consents and approvals, funding of up to a total of $1.5 million will be drawn down on the express basis that advances will be applied specifically and only to the expenses notified to and approved by the lender. Interest will be payable quarterly at 8% per year. The debenture will be secured by a fixed and floating charge over all assets and undertaking of MedX, and will be subject to customary provisions in the event of default. The debenture will be convertible into units at the option of the lender. Each unit shall comprise one common share and one share purchase warrant. MedX said the sole subscriber under the proposed placement is Forest Lane Holdings Ltd, a company controlled by David Hennigar, a director of the company, and accordingly this is a “related party transaction”.
Africa Oil Corp (TSX:AOI) said it repurchased a total of 1,667,480 common shares between November 14, 2022 and November 18, 2022 under a previously-announced share buyback program. Of the repurchased shares, 667,480 shares were bought back on the TSX and/or alternative Canadian trading systems, while 1,000,000 shares were on Nasdaq Stockholm. During the same period, Africa Oil cancelled 2,574,960 shares repurchased under the share buyback program. Since September 27, 2022, up to and including November 18, 2022, a total of 17,425,190 shares have been repurchased under the buyback program through the facilities of the TSX, Nasdaq Stockholm and/or alternative Canadian trading systems. A maximum of 40,482,356 shares may be repurchased between September 27, 2022 and September 26, 2023, or until such earlier date as the program is completed or terminated by the company.
Context Therapeutics (NASDAQ:CNTX) announced clinical data on onapristone extended release (ONA-XR) will be presented at the 2022 San Antonio Breast Cancer Symposium from December 6-10, 2022. “We are pleased that ONA-XR will be featured at SABCS. Initial clinical data from the SMILE trial will be presented, which is being conducted in collaboration with the Wisconsin Oncology Network, as well as a presentation providing an early look at the ELONA trial design that we recently initiated as part of our collaboration agreement with The Menarini Group. We’re excited to reconnect with the oncology community at SABCS, to further highlight the potential of ONA-XR to help improve the lives of people living with breast cancer, and to work toward creating new standards of care in the women’s oncology field that will make a meaningful impact,” said Martin Lehr, CEO of Context Therapeutics. Details on the presentations listed above are also available on the 2022 SABCS website: https://www.sabcs.org/2022-Symposium-Overview
Arizona Silver Exploration Inc. (TSX-V:AZS) has been granted an extension by the TSX Venture Exchange to complete its previously announced private placement worth up to $2 million. The new deadline is December 19, 2022. Completion of the private placement remains subject to the approval of the exchange.